Being younger at menopause onset and initiating hormone therapy after more than 5 years were both linked to increased tau vulnerability among women, according to a cross-sectional study published in JAMA Neurology.“Early trials and observational studies suggest that use of exogenous hormones, via HT, may ameliorate cognitive impairment in menopausal or postmenopausal individuals,”